|
US397782A
(en)
*
|
|
1889-02-12 |
|
Plunger water-closet |
|
NL254871A
(https=)
|
1959-08-14 |
|
|
|
|
GB1339764A
(en)
|
1971-03-29 |
1973-12-05 |
Ici Ltd |
Pyridine derivatives
|
|
US3939169A
(en)
|
1971-03-29 |
1976-02-17 |
Imperial Chemical Industries Limited |
Alkylene bis(pyridiniumareylene quaternary salts)
|
|
DE2942930A1
(de)
|
1979-10-24 |
1981-05-27 |
Basf Ag, 6700 Ludwigshafen |
Substituierte harnstoffe, deren herstellung und verwendung als herbizide
|
|
DE3147879A1
(de)
|
1981-12-03 |
1983-06-16 |
Basf Ag, 6700 Ludwigshafen |
1,3,5-triazinone, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
|
CA1185974A
(en)
|
1981-12-03 |
1985-04-23 |
Adolf Parg |
1,3,5-triazinones and their use for controlling undesirable plant growth
|
|
EP0138983B1
(en)
|
1983-03-29 |
1989-05-10 |
FMC Corporation |
N-phenyl-n'-(pyridinyl-n-oxide)urea plant regulators
|
|
US4787931A
(en)
|
1984-03-06 |
1988-11-29 |
Fmc Corporation |
N-phenyl-N'-(pyridinyl-N-oxide)urea plant regulators
|
|
US4672066A
(en)
|
1985-04-22 |
1987-06-09 |
Hoffmann-La Roche Inc. |
Derivatives of 4-acetyl-3-hydroxy-2-alkyl-phenoxycarboxylic acids
|
|
GB9027023D0
(en)
|
1990-12-12 |
1991-01-30 |
Wellcome Found |
Anti-atherosclerotic aryl compounds
|
|
US5162360A
(en)
*
|
1991-06-24 |
1992-11-10 |
Warner-Lambert Company |
2-heteroatom containing urea and thiourea ACAT inhibitors
|
|
GB9201180D0
(en)
|
1992-01-21 |
1992-03-11 |
Glaxo Group Ltd |
Chemical compounds
|
|
WO1993024458A1
(en)
|
1992-05-28 |
1993-12-09 |
Pfizer Inc. |
New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (acat)
|
|
ES2051647B1
(es)
|
1992-12-10 |
1995-01-16 |
Lipotec Sa |
Procedimiento para la preparacion de calcitonina de salmon.
|
|
GB9304920D0
(en)
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
|
EP0634402A1
(en)
|
1993-07-14 |
1995-01-18 |
Takeda Chemical Industries, Ltd. |
Isochinolinone derivatives, their production and use
|
|
US5547966A
(en)
|
1993-10-07 |
1996-08-20 |
Bristol-Myers Squibb Company |
Aryl urea and related compounds
|
|
EP0784612A1
(en)
|
1994-10-04 |
1997-07-23 |
Fujisawa Pharmaceutical Co., Ltd. |
Urea derivatives and their use as acat-inhibitors
|
|
EP0807105B1
(en)
|
1994-10-27 |
2004-06-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists
|
|
US6010026A
(en)
|
1994-11-22 |
2000-01-04 |
Aluminum Company Of America |
Assembly of aluminum can and threaded sleeve
|
|
US5556969A
(en)
|
1994-12-07 |
1996-09-17 |
Merck Sharp & Dohme Ltd. |
Benzodiazepine derivatives
|
|
US5624937A
(en)
|
1995-03-02 |
1997-04-29 |
Eli Lilly And Company |
Chemical compounds as inhibitors of amyloid beta protein production
|
|
GB9504361D0
(en)
*
|
1995-03-04 |
1995-04-26 |
Glaxo Spa |
Heterocyclic compounds
|
|
GB9511355D0
(en)
|
1995-06-06 |
1995-08-02 |
Fujisawa Pharmaceutical Co |
Urea derivatives
|
|
US5972975A
(en)
*
|
1995-12-08 |
1999-10-26 |
Merck & Co., Inc. |
Substituted 2-aminopyridines as inhibitors of nitric oxide synthase
|
|
US6005008A
(en)
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
DK0915859T3
(da)
*
|
1996-07-23 |
2003-03-03 |
Neurogen Corp |
Visse substituerede benzylaminderivater; en ny klasse af Neuropeptid Y1-specifikke ligander
|
|
IT1284198B1
(it)
|
1996-07-30 |
1998-05-08 |
Beniamino Anzalone |
Carne vegetale
|
|
US6174905B1
(en)
*
|
1996-09-30 |
2001-01-16 |
Mitsui Chemicals, Inc. |
Cell differentiation inducer
|
|
AUPO390996A0
(en)
|
1996-11-29 |
1996-12-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Urea derivatives
|
|
JP2002241368A
(ja)
|
1997-02-18 |
2002-08-28 |
Shionogi & Co Ltd |
新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
|
|
WO1998041510A1
(en)
|
1997-03-14 |
1998-09-24 |
Shionogi & Co., Ltd. |
Novel benzolactam derivatives and medicinal compositions comprising the same
|
|
AU7526798A
(en)
|
1997-04-18 |
1998-11-27 |
Smithkline Beecham Plc |
Acetamide and urea derivatives, process for their preparation and their use in the treatment of cns disorders
|
|
WO1998052558A1
(en)
|
1997-05-23 |
1998-11-26 |
Bayer Corporation |
INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
|
|
ATE399007T1
(de)
|
1997-05-23 |
2008-07-15 |
Bayer Pharmaceuticals Corp |
Raf kinase hemmer
|
|
ES2189238T3
(es)
*
|
1997-11-05 |
2003-07-01 |
Choongwae Pharma Corp |
Nuevo derivado de genipina que tiene actividad protectora del higado.
|
|
US7517880B2
(en)
*
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
MXPA00006233A
(es)
|
1997-12-22 |
2002-09-18 |
Bayer Ag |
Inhibicion de la actividad de la cinasa p38 utilizando ureas heterociclicas sustituidas.
|
|
SK286213B6
(sk)
|
1997-12-22 |
2008-05-06 |
Bayer Corporation |
Substituované heterocyklické močoviny, farmaceutický prípravok ich obsahujúci a ich použitie
|
|
BR9814375A
(pt)
|
1997-12-22 |
2002-05-21 |
Bayer Ag |
Inibição de raf cinase usando difenil uréias substituìdas simétricas e assimétricas
|
|
JP3887769B2
(ja)
|
1997-12-22 |
2007-02-28 |
バイエル コーポレイション |
対称および非対称ジフェニル尿素を用いるｐ３８キナーゼの阻害
|
|
JP4405602B2
(ja)
|
1998-04-16 |
2010-01-27 |
バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト |
ヒストン脱アセチル化酵素阻害剤
|
|
US6329395B1
(en)
|
1998-06-08 |
2001-12-11 |
Schering Corporation |
Neuropeptide Y5 receptor antagonists
|
|
PE20000564A1
(es)
|
1998-06-08 |
2000-07-05 |
Schering Corp |
Antagonistas receptores y5 de neuropeptidos
|
|
US6407124B1
(en)
|
1998-06-18 |
2002-06-18 |
Bristol-Myers Squibb Company |
Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
|
|
EP1104763A4
(en)
|
1998-08-11 |
2001-10-17 |
Sumitomo Pharma |
NAPHTHYRIDINE DERIVATIVES
|
|
US6331541B1
(en)
|
1998-12-18 |
2001-12-18 |
Soo S. Ko |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
|
JP2000256194A
(ja)
|
1999-01-06 |
2000-09-19 |
Mitsui Chemicals Inc |
核内レセプタ作動薬およびその効果増強剤
|
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
ATE538794T1
(de)
|
1999-01-13 |
2012-01-15 |
Bayer Healthcare Llc |
Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
|
|
US6402960B1
(en)
|
1999-03-01 |
2002-06-11 |
The Regents Of The University Of California |
Thiacrown polymers for removal of mercury from waste streams
|
|
PL215901B1
(pl)
*
|
1999-04-15 |
2014-02-28 |
Bristol Myers Squibb Co |
Cykliczny inhibitor bialkowych kinaz tyrozynowych, jego zastosowanie oraz kompozycja farmaceutyczna zawierajaca taki zwiazek
|
|
US6410254B1
(en)
|
1999-05-18 |
2002-06-25 |
Cytokinetics |
Compositions and assays utilizing ADP or phosphate for detecting protein modulators
|
|
DE19921498A1
(de)
|
1999-05-08 |
2000-11-16 |
Clariant Gmbh |
Verfahren zur Herstellung von wäßrigen Diazoniumsalzlösungen
|
|
ATE312823T1
(de)
|
1999-07-09 |
2005-12-15 |
Boehringer Ingelheim Pharma |
Verfahren zur herstellung heteroarylsubstituierter ureaverbindungen
|
|
US6958333B1
(en)
|
1999-07-26 |
2005-10-25 |
Banyu Pharmaceutical Co., Ltd. |
Biarylurea derivatives
|
|
CA2385972A1
(en)
|
1999-10-01 |
2001-04-12 |
Haruhisa Ogita |
Novel diarylamide derivatives and use thereof as medicines
|
|
WO2001036403A1
(en)
|
1999-11-16 |
2001-05-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Urea derivatives as anti-inflammatory agents
|
|
HN2001000008A
(es)
|
2000-01-21 |
2003-12-11 |
Inc Agouron Pharmaceuticals |
Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
|
|
JP2001278886A
(ja)
*
|
2000-03-28 |
2001-10-10 |
Dai Ichi Seiyaku Co Ltd |
ベンゾオキサジン誘導体及びこれを含有する医薬
|
|
US6495337B1
(en)
|
2000-03-29 |
2002-12-17 |
Cytokinetics, Inc. |
High throughput sarcomeric assay
|
|
WO2001098269A2
(en)
|
2000-06-21 |
2001-12-27 |
Bristol-Myers Squibb Pharma Company |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
|
GB0015601D0
(en)
*
|
2000-06-26 |
2000-08-16 |
Ferring Bv |
Novel antidiuretic agents
|
|
GB0015904D0
(en)
|
2000-06-28 |
2000-08-23 |
Hoffmann La Roche |
Inhibitors of HPV E1 helicase enzyme
|
|
AU2001271631A1
(en)
*
|
2000-06-30 |
2002-01-14 |
Ortho-Mcneil Pharmaceutical, Inc. |
Useful aroyl aminoacyl pyrrole compounds
|
|
ES2291329T3
(es)
|
2000-07-18 |
2008-03-01 |
Dainippon Sumitomo Pharma Co., Ltd. |
Inhibidores de la recaptacion de serotonina.
|
|
GB0017676D0
(en)
|
2000-07-19 |
2000-09-06 |
Angeletti P Ist Richerche Bio |
Inhibitors of viral polymerase
|
|
US20020173507A1
(en)
|
2000-08-15 |
2002-11-21 |
Vincent Santora |
Urea compounds and methods of uses
|
|
US6645990B2
(en)
*
|
2000-08-15 |
2003-11-11 |
Amgen Inc. |
Thiazolyl urea compounds and methods of uses
|
|
US6573264B1
(en)
|
2000-10-23 |
2003-06-03 |
Cv Therapeutics, Inc. |
Heteroaryl alkyl piperazine derivatives
|
|
US20030045552A1
(en)
|
2000-12-27 |
2003-03-06 |
Robarge Michael J. |
Isoindole-imide compounds, compositions, and uses thereof
|
|
US7091353B2
(en)
*
|
2000-12-27 |
2006-08-15 |
Celgene Corporation |
Isoindole-imide compounds, compositions, and uses thereof
|
|
JP2004532187A
(ja)
|
2001-01-25 |
2004-10-21 |
ギルフォード ファーマシュウティカルズ インコーポレイテッド |
三置換カルボサイクリックサイクロフィリン結合化合物とその用途
|
|
JP2002220338A
(ja)
|
2001-01-26 |
2002-08-09 |
Banyu Pharmaceut Co Ltd |
ビアリールウレア化合物又はその塩を有効成分として含有するＣｄｋ４及び／又はＣｄｋ６阻害剤
|
|
GB0117950D0
(en)
|
2001-02-16 |
2001-09-19 |
Aventis Pharma Inc |
Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
|
|
DE10110749A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Substituierte Aminodicarbonsäurederivate
|
|
CA2443950C
(en)
|
2001-04-20 |
2011-10-18 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
WO2002092576A1
(en)
|
2001-05-16 |
2002-11-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Diarylurea derivatives useful as anti-inflammatory agents
|
|
EP1395561A1
(en)
|
2001-05-25 |
2004-03-10 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Carbamate and oxamide compounds as inhibitors of cytokine production
|
|
AU2002346048A1
(en)
|
2001-06-07 |
2002-12-16 |
Merck And Co., Inc. |
Benzodiazepine bradykinin antagonists
|
|
JP2004536845A
(ja)
|
2001-07-11 |
2004-12-09 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
サイトカイン媒介疾患の治療方法
|
|
DE10134482A1
(de)
|
2001-07-16 |
2003-01-30 |
Bayer Ag |
Substituierte Isoindole und ihre Verwendung
|
|
AUPR688101A0
(en)
|
2001-08-08 |
2001-08-30 |
Luminis Pty Limited |
Protein domains and their ligands
|
|
WO2003022820A1
(en)
|
2001-09-06 |
2003-03-20 |
Bristol-Myers Squibb Pharma Company. |
Heteroaromatic substituted cyclopropane as corticotropin releasing hormone
|
|
US7361679B2
(en)
|
2001-09-12 |
2008-04-22 |
Kaken Pharmaceutical Co., Ltd. |
2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
|
|
US7320126B2
(en)
*
|
2001-11-06 |
2008-01-15 |
Sandisk Corporation |
Implementation of in system programming to update firmware on memory cards
|
|
TWI249515B
(en)
|
2001-11-13 |
2006-02-21 |
Theravance Inc |
Aryl aniline beta2 adrenergic receptor agonists
|
|
EP1503986B1
(en)
|
2001-12-21 |
2015-09-30 |
Cytokinetics, Inc. |
Compositions and methods for treating heart failure
|
|
US20030207872A1
(en)
|
2002-01-11 |
2003-11-06 |
Bayer Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
WO2003062224A1
(en)
|
2002-01-17 |
2003-07-31 |
Eli Lilly And Company |
Aza-cyclic compounds as modulators of acetylcholine receptors
|
|
WO2003062235A1
(en)
|
2002-01-17 |
2003-07-31 |
Eli Lilly And Company |
Modulators of acetylcholine receptors
|
|
MXPA04007832A
(es)
|
2002-02-11 |
2005-09-08 |
Bayer Pharmaceuticals Corp |
Aril-ureas con actividad inhibitoria de angiogenesis.
|
|
DE10208986A1
(de)
|
2002-02-28 |
2003-09-11 |
Aventis Pharma Gmbh |
Verwendung substituierter 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one zur Herstellung von Arzneimitteln mit hemmender Wirkung an der pankreatischen Lipase
|
|
AU2003221322A1
(en)
|
2002-03-07 |
2003-09-16 |
Sds Biotech K.K. |
Substituted isoxazole alkylamine derivative and agri- and horticultural fungicide
|
|
TW200400035A
(en)
|
2002-03-28 |
2004-01-01 |
Glaxo Group Ltd |
Novel compounds
|
|
KR20040095311A
(ko)
|
2002-03-28 |
2004-11-12 |
어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. |
프로스타글란딘 ｆ 수용체의 모듈레이터로서의 티아졸리딘카르복사미드 유도체
|
|
EP1500643A4
(en)
|
2002-04-03 |
2007-03-28 |
Dainippon Sumitomo Pharma Co |
benzamidine
|
|
US7105505B2
(en)
*
|
2002-04-18 |
2006-09-12 |
Schering Corporation |
Benzimidazole derivatives useful as histamine H3 antagonists
|
|
PT1499316E
(pt)
|
2002-04-18 |
2008-06-30 |
Schering Corp |
Derivados de (1-4-piperidinil)benzimidazole úteis como antagonistas de histamina h3
|
|
JP2005529890A
(ja)
|
2002-04-23 |
2005-10-06 |
ブリストル−マイヤーズ スクイブ カンパニー |
キナーゼ阻害剤として有用なアリールケトンピロロトリアジン化合物
|
|
US20030236287A1
(en)
|
2002-05-03 |
2003-12-25 |
Piotrowski David W. |
Positive allosteric modulators of the nicotinic acetylcholine receptor
|
|
EP1515940A2
(en)
|
2002-05-17 |
2005-03-23 |
Lica Pharmaceuticals A/S |
Aminoalkoxy-functional chalcones
|
|
TW200406374A
(en)
|
2002-05-29 |
2004-05-01 |
Novartis Ag |
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
|
|
WO2004000831A1
(en)
|
2002-06-24 |
2003-12-31 |
Schering Corporation |
Indole derivatives useful as histamine h3 antagonists
|
|
BR0312023A
(pt)
|
2002-06-27 |
2005-03-22 |
Novo Nordisk As |
Composto, composto ativador da glicose cinase, método para evitar a hipoglicemia, uso de um composto, e, composição farmacêutica
|
|
CA2493026C
(en)
|
2002-07-31 |
2011-05-24 |
Bayer Schering Pharma Aktiengesellschaft |
Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridines
|
|
GB0218147D0
(en)
|
2002-08-05 |
2002-09-11 |
Oxford Glycosciences Uk Ltd |
Novel compounds
|
|
JP4606876B2
(ja)
|
2002-08-27 |
2011-01-05 |
キッセイ薬品工業株式会社 |
ピラゾール誘導体、それを含有する医薬組成物及びその医薬用途
|
|
WO2004022561A1
(en)
|
2002-09-04 |
2004-03-18 |
Schering Corporation |
Pyrazolopyrimidines as cyclin-dependent kinase inhibitors
|
|
US6915814B2
(en)
*
|
2002-09-04 |
2005-07-12 |
Dara Cheng |
Transparent pipe trap with means of enhancing the biodegradation of sink effluents
|
|
WO2004024729A1
(en)
|
2002-09-10 |
2004-03-25 |
Pfizer Products Inc. |
Diazabicyclic compounds useful in the treatment of cns and other disorders
|
|
AU2003285454A1
(en)
|
2002-10-29 |
2004-05-25 |
L'oreal |
Hair treatment composition containing a styryl-pyrazole compound
|
|
CA2511970C
(en)
|
2003-01-14 |
2012-06-26 |
Cytokinetics, Inc. |
Urea derivatives useful in the treatment of heart failure
|
|
US7557129B2
(en)
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
|
US7531553B2
(en)
*
|
2003-03-21 |
2009-05-12 |
Amgen Inc. |
Heterocyclic compounds and methods of use
|
|
AU2003902073A0
(en)
|
2003-05-01 |
2003-05-15 |
Kevin Raymond Deguara |
A lighting substrate
|
|
JP4806628B2
(ja)
|
2003-05-05 |
2011-11-02 |
プロビオドルグ エージー |
グルタミニルシクラーゼ阻害剤
|
|
WO2004101529A1
(ja)
|
2003-05-19 |
2004-11-25 |
Ono Pharmaceutical Co., Ltd. |
含窒素複素環化合物およびその医薬用途
|
|
WO2004113274A2
(en)
|
2003-05-20 |
2004-12-29 |
Bayer Pharmaceuticals Corporation |
Diaryl ureas with kinase inhibiting activity
|
|
GB0316915D0
(en)
*
|
2003-07-18 |
2003-08-20 |
Glaxo Group Ltd |
Compounds
|
|
JP2007515400A
(ja)
|
2003-11-28 |
2007-06-14 |
ノバルティス アクチエンゲゼルシャフト |
タンパク質キナーゼ依存性疾患の処置におけるジアリール尿素誘導体
|
|
TW200530236A
(en)
|
2004-02-23 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Heteroaryl phenylurea
|
|
EP1751136B1
(en)
|
2004-05-07 |
2014-07-02 |
Amgen Inc. |
Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
|
|
JP5080970B2
(ja)
|
2004-06-17 |
2012-11-21 |
サイトキネティクス・インコーポレーテッド |
心疾患を治療するための置換尿素誘導体
|
|
WO2006009729A2
(en)
|
2004-06-18 |
2006-01-26 |
Medtronic, Inc. |
Methods and devices for occlusion of an atrial appendage
|
|
US7176222B2
(en)
*
|
2004-07-27 |
2007-02-13 |
Cytokinetics, Inc. |
Syntheses of ureas
|
|
WO2006089871A2
(en)
|
2005-02-23 |
2006-08-31 |
Neurosearch A/S |
Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias
|
|
US7538223B2
(en)
|
2005-08-04 |
2009-05-26 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
|
TW200808321A
(en)
|
2005-12-15 |
2008-02-16 |
Cytokinetics Inc |
Certain chemical entities, compositions and methods
|
|
US20070197505A1
(en)
|
2005-12-15 |
2007-08-23 |
Morgan Bradley P |
Certain chemical entities, compositions and methods
|
|
US7825120B2
(en)
|
2005-12-15 |
2010-11-02 |
Cytokinetics, Inc. |
Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas
|
|
US20070208000A1
(en)
|
2005-12-15 |
2007-09-06 |
Morgan Bradley P |
Certain chemical entities, compositions and methods
|
|
EP1959962A2
(en)
|
2005-12-16 |
2008-08-27 |
Cytokinetics, Inc. |
Certain chemical entities, compositions, and methods
|
|
EP1962852B1
(en)
|
2005-12-19 |
2017-01-25 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
|
US7672247B2
(en)
*
|
2006-02-23 |
2010-03-02 |
International Business Machines Corporation |
Evaluating data processing system health using an I/O device
|
|
CA2902424A1
(en)
|
2013-03-14 |
2014-09-25 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
|
DK2970123T4
(da)
|
2013-03-14 |
2026-01-26 |
Amgen Inc |
Krystallinsk dihydrochloridhydratsalt af omecamtiv mecarbil og fremgangsmåde til fremstilling heraf
|
|
MX379899B
(es)
|
2015-06-26 |
2025-03-11 |
Cytokinetics Inc |
Terapia de combinacion de activador de miosina cardiaca e inhibidor de corriente if del nodo sinusal
|
|
CN105572945B
(zh)
|
2016-03-10 |
2019-06-14 |
京东方科技集团股份有限公司 |
阵列基板、偏光片贴附膜及其制备方法
|
|
SMT202100472T1
(it)
|
2017-06-30 |
2021-09-14 |
Amgen Inc |
Sintesi di omecamtiv mecarbil
|
|
EP3594199B1
(en)
|
2018-07-09 |
2020-07-01 |
F.I.S.- Fabbrica Italiana Sintetici S.p.A. |
Crystalline 2-fluoro-3-nitrotoluene and process for the preparation thereof
|
|
JP2021534138A
(ja)
|
2018-08-17 |
2021-12-09 |
アムジエン・インコーポレーテツド |
オメカムチブメカルビルの塩及び結晶形態
|
|
WO2020131574A1
(en)
|
2018-12-18 |
2020-06-25 |
Amgen Inc. |
Method of reducing aromatic nitro compounds
|
|
CN115279349A
(zh)
|
2020-02-10 |
2022-11-01 |
安进股份有限公司 |
奥美卡替莫卡必尔片剂
|
|
US12194039B2
(en)
|
2020-11-12 |
2025-01-14 |
Amgen Inc |
Methods of treating heart failure by administering omecamtiv mecarbil
|
|
JP7843295B2
(ja)
|
2021-03-10 |
2026-04-09 |
アムジェン インコーポレイテッド |
オメカムチブメカルビルの合成
|
|
US11986474B1
(en)
|
2023-06-27 |
2024-05-21 |
Cytokinetics, Incorporated |
Methods for treating heart failure by administering cardiac sarcomere activators
|